The Human Tumor Necrosis Factor alpha (Hu TNFα) ELISA quantitates Hu TNFα in human serum, plasma, cell culture supernatants, amniotic fluid, synovial fluid, urine or other body fluids. The assay will exclusively recognize both natural and…
The Human Tumor Necrosis Factor alpha (Hu TNFα) ELISA quantitates Hu TNFα in human serum, plasma, cell culture supernatants, amniotic fluid, synovial fluid, urine or other body fluids. The assay will exclusively recognize both natural and recombinant Hu TNFα. Principle of the method The Human TNFα solid-phase sandwich ELISA (enzyme-linked immunosorbent assay) is designed to measure the amount of the target bound between a matched antibody pair. A target-specific antibody has been pre-coated in the wells of the supplied microplate. Samples or controls are then added into these wells and bind to the immobilized (capture) antibody. The sandwich is formed by the binding of the second (detector) antibody to the target on a different epitope from the capture antibody. An antibody conjugated with enzyme binds the formed sandwich. After incubation and washing steps to rid the microplate of unbound substances, a substrate solution is added that reacts with the enzyme-antibody-target complex to produce measurable signal. The intensity of this signal is directly proportional to the concentration of target present in the original specimen. Rigorous validation Each manufactured lot of this ELISA kit is quality tested for criteria such as sensitivity, specificity, precision, and lot-to-lot consistency. See manual for more information on validation.
Tumor necrosis factor is a polypeptide cytokine produced by monocytes and macrophages. It works as a multi-power modulator of the immune response and also acts as a powerful pyrogen. TNF-alpha circulates throughout the body in response to stimuli (infectious agents or tissue lesions), activating neutrophils, modifying the properties of vascular endothelial cells, regulating metabolic activities of other tissues, and exhibiting tumour activity by inducing localized blood clotting. TNF-alpha also inhibits lipoprotein lipase activity, resulting in cachexia, a physical condition of decay. The activation of B cells by the virus of Epstein Barr may be inhibited by TNF-alpha. Because of its various actions throughout the immune system, TNF alpha can play a role in the pathogenesis of many pathological states. Production of TNF alpha is mediated by the action of lymphokins and endotoxins on macrophages. Purified monocytes produce TNF alpha within four hours of recombinant l的IL-2 stimulation and there is in vitro evidence suggesting that TNF alpha is expressed at high levels and with prolonged kinetics in CD2 and CD28-stimulated T cells. The secretion of TNF alpha is enhanced by gamma interferon. TNF induces or subsequently improves the specific production of Class I MHC antigen, GM-CSF and L-IL-1.
Sensitivity
Sensitivity of the dosage: 1.65 pg/ml.
Measurement range
Dose range: 7.8-500 pg/ml.
Duration of dosing
Total duration of dosing: 3 h 10 min.
Reproducibility
Coefficient of variation within dose 6%, interdose 9.3%.
Technical specifications
| General |
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 15531747 |
| Specifications |
| Accession number | P01375 |
| Dose range | 7.8-500 pg/ml |
| Sensitivity of the dosage | 1.65 pg/ml |
| Conjugate | Biotin |
| Product type | Kit ELISA |
| Type of sample | Amniotic liquid, Synovial liquid, Serum, Surnatant, Synovial Fluid, Urine |
| Target species | Human |
| For use with (application) | ELISA |
| For use with (equipment) | Colorimetric microplate reader |
| Genetic identification (Enter) | 7124 |
| Gene symbol(s) | DIF-alpha,TNFA,TNFSF2,TNLG1F,TNF |
| Coefficient of inter-dose variation | 9.3% |
| Coefficient of intra-dose variation | 6% |
| Contents of kits | 96-well pre-coated microplate, Biotinylated detection antibody, Sample diluent, Sample diluent, Standard curve strips, Wash buffer concentrate, Substrate solution, Substrate solution, 10x lysis pad, Adhesive plate covers, Adhesive plate covers |
| Marker or dye | HRP |
| Quantity | 128 Tests |
| Regulatory status | RUO |
| Synonym | Mascetine, tumour necrosis factor alpha, DIF |
| Target | Human |
| Test time | 20 min |
| Physical characteristics |
| Volume of sample | Amniotic liquid, 50 μl; plasma, 50 μl; serum, 50 μl; supernatant, 50 μl; synovial liquid, 50 μl; urine, 50 μl |
| Storage and shipping |
| Storage conditions | -20°C |
| Total duration of dosing | 3 h 10 min |
Origin and customs
| Manufacturer ref. | BMS223INST |
|---|
| Country of origin | Autriche |
|---|
| HS customs code | 3002 15 00 00 |
|---|
A question or a specific configuration?
Contact us for a quote.